Posted by Michael Wonder on 16 Nov 2021
FDA authorises marketing of virtual reality system for chronic pain reduction
16 November 2021 - The U.S. FDA today authorized marketing of EaseVRx, a prescription-use immersive virtual reality system that uses cognitive behavioral therapy and other behavioural methods to help with pain reduction in patients 18 years of age and older with diagnosed chronic lower back pain.
EaseVRx employs the principles of cognitive behavioral therapy and other behavioural therapy techniques for the purpose of reduction of pain and pain interference.
